Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Download references

This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor

Highly Accessed

Tumor metastasis to bone

Mandeep S Virk and Jay R Lieberman*

Arthritis Research & Therapy 2007, 9(Suppl 1):S5  doi:10.1186/ar2169

Include


Format